Life Sciences

Tessa buys Euchloe for suite of checkpoint inhibitors

March 23, 2017

Tessa Therapeutics has bought Euchloe Bio for its suite of checkpoint inhibitors. The takeover gives Tessa antibodies against PD-1, PD-L1, CTLA-4 and other targets that it sees complementing its own virus-specific T cells. Euchloe spun out of A*STAR’s Singapore Immunology Network last year, only to..

BioLineRx buys Agalimmune to expand cancer pipeline

March 23, 2017

BioLineRx has bought Agalimmune to expand its immuno-oncology pipeline. The takeover adds the synthetic alpha-gal immunotherapy AGI-134 to BioLineRx’s pipeline as the drug nears the start of a first-in-human trial in solid tumors. Tel Aviv, Israel-based BioLineRx is paying $6 million (€5.6 million) upfront—split evenly..

Amgen to open Tampa center, creating up to 450 jobs

March 23, 2017

Biotechnology giant Amgen is opening a facility in Tampa this October with promises to create as many as 450 jobs here by 2018. The facility will be primarily back-office operations spanning four floors of Corporate Center One in Tampa, which neighbors Tampa International Airport to..

GSK starts $175M plant to boost production of vaccine star Bexsero

March 22, 2017

Vaccines have been one of the financial bright spots for GlaxoSmithKline and Bexsero, which it picked up in its asset swap with Novartis, has had stellar sales. To boost both, GSK is building a $175 million plant in Germany so it can expand production of..

Trump’s pushing GOP to put ‘competitive bidding’ on drugs in healthcare bill

March 21, 2017

How would a “competitive bidding process” for drugs work? We may soon find out, if President Donald Trump gets his way with the Republican healthcare bill. Trump assured supporters at a Monday rally that drug prices are still a top priority for him—and to back..

Eli Lilly says it’s cutting an average of 50% off list prices

March 21, 2017

Heightened pressure from pharmacy benefit managers and increased competition among drugmakers are taking a big bite out of Eli Lilly’s list-price hikes—an 11-percentage-point bite, on average, the company said in a new report. After raising list prices an average of 14% in 2016, and wheeling..

Bristol-Myers Squibb, CytomX pen expanded $3.6B biobucks research deal

March 21, 2017

Fierce 15 winner CytomX is in line for a $200 million upfront payday and potentially billions in biobucks from partner Bristol-Myers Squibb as the Big Pharma signs an updated deal on eight additional targets using CytomX’s Probody platform. This builds on the 2014 deal between..

Connected fetal monitor maker Monica acquired by GE Healthcare

March 20, 2017

UK-based Monica Healthcare, one of the earliest digital health companies, has been acquired by GE Healthcare. While the terms of the deal were not disclosed, investor Catapult Ventures shared that it recieved a 3.5x return on its investment. MobiHealthNews’s reporting has the company’s total funding..

J&J chief Gorsky straddles Trump’s globalism divide

March 20, 2017

Amid uncertainty for pharma as President Donald Trump embarks on his quest of putting “America First,” Johnson & Johnson CEO Alex Gorsky played down the potential fallout for his company during a CNBC interview Monday. Gorsky, visiting China for a business summit, told CNBC’s Eunice..

Hot buyout target Stada rolls out cost-cutting measures

March 17, 2017

The bidding war for Germany’s Stada is heating up, with private equity firms, Chinese drugmakers and others rumored to be in the mix. But their offers so far aren’t high enough to woo the company, which is rolling out cost-cutting measures and new guidance in..